ISTH Academy

• Know the Risk: Are Your Patient Protected? Michael Streiff, MD
• Critical Care: Preventing Cancer-Associated Thrombosis in Your Patients, Alok Khorana, MD
• Conquer the Clot: Treating VTE in Your Patients With Cancer, Tzu-Fei Wang, MD

This activity is accredited for CME, upon completion click here to complete the evaluation and claim your credit. Please see the full instructions below.

FACULTY
Alok A. Khorana, MD, FACP, FASCO
Sondra and Stephen Hardis Chair in Oncology Research
Professor of Medicine, Cleveland Clinic Lerner College of Medicine
Taussig Cancer Institute and Case Comprehensive Cancer Center
Cleveland, Ohio

Michael B. Streiff, MD, FACP
Professor of Medicine and Pathology
Medical Director, Johns Hopkins Anticoagulation Service
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Chairman, NCCN Guidelines for Venous Thromboembolic Disease
Baltimore, Maryland

Tzu-Fei Wang, MD, MPH
Associate Professor, Division of Hematology, Department of Medicine
University of Ottawa at The Ottawa Hospital
Associate Scientist
Ottawa Hospital Research Institute
Ottawa, Canada

METHOD OF PARTICIPATION/HOW TO RECEIVE CREDIT
Technical Requirements: http://www.francefoundation.com/general-requirements.html

1. ​There are no fees for participating in and receiving credit for this activity
2. Review the activity objectives and CME/CE information
3. Complete the CME/CE activity
4. Complete the online posttest, here. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed. Document1
5. Complete the CME/CE evaluation/attestation form. This form provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
6. Credit documentation/reporting:
   • If you are requesting AMA PRA Category 1 Credits™ or a certificate of participation—your CME/CE certificate will be available for download

 
ACCREDITED PROVIDER
This activity is provided by The France Foundation in collaboration with the International Society on Thrombosis and Haemostasis (ISTH).
 
TARGET AUDIENCE
This activity is intended for hematologists/oncologists, medical oncologists, nurse practitioners (NPs), physician assistants (PAs), oncology pharmacists, and other health care professionals who are involved in the prevention and treatment of venous thromboembolism (VTE) in patients with cancer.
 
STATEMENT OF NEED
The prevention and treatment of cancer-associated thrombosis remains one of the most challenging areas of clinical medicine due to the intersection of cancer care and thrombosis management. Despite recent advances in patient risk stratification, prevention and treatment strategies, which have provided clinicians and patients unprecedented management choices, individualized patient-centered management is needed to deliver optimal care.
 
ACCREDITATION STATEMENT  
 
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The France Foundation (TFF) and the International Society on Thrombosis and Haemostasis (ISTH). The France Foundation is accredited by the ACCME to provide continuing medical education for physicians.
 
CREDIT DESIGNATION
Physicians
The France Foundation designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Nurses
Nurses who are certified by the American Nurses Credentialing Center (ANCC) may utilize activities that are certified by ACCME-accredited providers toward their requirement for certification renewal by the ANCC. A certificate of attendance will be provided by The France Foundation, an ACCME accredited provider.
 
Disclosure Policy
In accordance with the ACCME Standards for Commercial Support, TFF and the ISTH require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TFF and the ISTH resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, TFF and the ISTH seek to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF and the ISTH are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.
 
Activity Staff Disclosures
The planners, reviewers, editors, staff, CME committee, and other members at The France Foundation who control content have no relevant financial relationships to disclose.
 
The planners, reviewers, editors, staff, CME committee, and other members at ISTH who control content have no relevant financial relationships to disclose.
 
Faculty Disclosures-Activity Faculty
The faculty listed below report that they have no relevant financial relationships to disclose:

• Alok A. Khorana, MD, FACP, FASCO, serves as a consultant for Anthos, Bayer, BMS, Halozyme, Janssen, and Sanofi
• Michael B. Streiff, MD, FACP, serves as a consultant for Bayer, Bristol-Myers Squibb, Coagulo, Dispersol, Janssen, and Pfizer. He also receives research support from AHRQ, Janssen, NIH/NHLBI, Novo Nordisk, PCORI, Sanofi, and Tremeau.
• Tzu-Fei Wang, MD, MPH, serves as a consultant for Servier. She also receives contract research support from Leo Pharma.
   

Disclosure of Unlabeled Use
TFF and the ISTH require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF and the ISTH do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.
 
Commercial Support Acknowledgment
This activity is supported by an educational grant from the BMS/Pfizer Alliance.
 
Disclaimer
The France Foundation and ISTH present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation, ISTH, and the commercial supporter(s) assume no liability for the information herein.
 
COPYRIGHT INFORMATION
Copyright © 2021 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

• The materials are to be used solely for personal, noncommercial, informational, and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
• Materials may not be published, uploaded, posted, or transmitted (other than as set forth herein), without The France Foundation's prior written permission

 
PRIVACY POLICY
The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except when such information is required for reporting purposes to the ACCME.

The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information that we have collected from you.

Additional information regarding The France Foundation’s Privacy Policy can be viewed at http://www.francefoundation.com/privacy.

CONTACT INFORMATION
If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.

Upon completion of the activity, participants should be able to:

• ​Identify appropriate patients for primary VTE prophylaxis through risk stratification assessments
• Establish a plan for prevention of VTE in patients at elevated risk
• Select appropriate therapy to treat VTE in the patient with cancer, and select appropriate duration of treatment
• Discuss with patients risk and prevention of VTE